IDAHO FALLS, Idaho & LANE COVE, Australia – October 23, 2025. International Isotopes, Inc. (“INIS”), a leading U.S. provider of medical isotopes and nuclear medicine solutions, today announced an exclusive partnership agreement with Australia-based Globalsonics Research Pty Ltd (“Globalsonics”). Under the terms of the agreement, INIS will become the authorized distributor, installer, and service provider of Globalsonics’ advanced radiation detection and safety instrumentation across North America.
This strategic alliance brings together INIS’s deep capabilities in radiopharmaceuticals, medical devices, and nuclear medicine infrastructure with Globalsonics’ state-of-the-art instrumentation for radiation monitoring, measurement, shielding, and protection. The collaboration is designed to enhance access to cutting-edge technology for nuclear medicine clinics, radiopharmacies, research institutions, and regulatory bodies throughout the U.S. and Canada.
“We are excited to partner with Globalsonics and bring their world-class radiation instrumentation to North America,” said Shahe Bagerdjian, President & CEO of International Isotopes. “This agreement is consistent with our mission to enable broader access to advanced nuclear medical technologies, backed by local service and support.”
About International Isotopes (INIS)
International Isotopes Inc. (INIS), established in 1995, with its headquarters in Idaho Falls, ID, USA, manufactures a wide range of radioisotope-focused products. INIS manufactures and supplies generic sodium iodide I-131 radio-pharmaceutical drug product for hyperthyroidism and thyroid cancer. INIS provides contract manufacturing of various drug products as well as radioisotope API supply for 3rd party theranostics clients INIS manufactures and distributes a complete line of calibration and reference standards for nuclear pharmacies and SPECT/PET imaging systems as well as industrial calibration standards under its RadQual brand. The Company also manufactures Cobalt-60 sealed source products. For more information, visit intisoid.com.
About Globalsonics Research
Globalsonics Research Pty Ltd (based in Lane Cove, New South Wales) is recognized globally for its design, development, and delivery of radiation detection, measurement, and protection systems. The company’s product portfolio includes fixed and portable detection systems, environmental monitoring stations, contamination monitors, spectrometers, shielding materials, and related calibration systems.
International Isotopes Inc. Safe Harbor Statement
Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934,including statements with respect to the Company’s future growth expectations. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance, or achievements of International Isotopes Inc. to be materially different from any future results, performance or achievements of the Company expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in the Company’s filings with the Securities and Exchange Commission at www.sec.gov, including its Annual Report on Form 10-K for the year ended December 31, 2023. Investors, potential investors, and other readers are urged to consider these factors carefully in evaluating the forward- looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
International Isotopes Contact:
admin@intisoid.com
intisoid.com
208.524.5300